A pilot study on predictors of severe radiation pneumonitis by Breathomics

A pilot study on predictors of severe radiation pneumonitis by Breathomics - Breathomics for severe radiation pneumonitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049324

Enrollment

Registered

2022-11-01

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Non-small lung cancer 2) stage IIIA-C 3)planning definitive chemoradiotherapy 4)case with written informed consent.

Exclusion criteria

Exclusion criteria: 1)Cases with contralateral hilar lymph node metastasis 2)Cases without contrast-enhanced CT or FDG-PET 3)planning radiotherapy alone 4)Cases with a history of radiotherapy to the chest 5)Cases with clear interstitial pneumonia or active infectious pneumonia 6)Cases with other active malignancy 7)Cases judged to be ineligible by the principal investigator or co-investigator

Design outcomes

Primary

Measure	Time frame
Radiation pneumonitis severity (Grade 0-1 vs. Grade 2 or higher)	—

Countries

Japan

Contacts

Public ContactKeiichi Jingu

Tohoku University Graduate School of Medicine Depart of Radiation Oncology

kjingurad@yahoo.co.jp0227177312

Outcome results